Semaglutide
Use in type 2 diabetes and weight management
The presentation covers:
- GLP1a medications
- Mechanism of action
- Indications and contra-indications
- Ozempic and Wegovy
- Client selection
- Availability
- Length of treatment
- Clinical scenarios
Read a review of the presentation here
You may also be interested in our complimentary presentation by Associate Professor Ralph Audehm on Glucose lowering medications
Watching this presentation and completing the assessment can contribute towards assessable Continuing Professional Development hours
About the Presenter
Dr Terri-Lynne South, BSc, MBBS (Hons), FRACGP, Grad Dip Nut & Diet
Terri-Lynne South is dual qualified as both a Medical Doctor and Dietitian. She is the Medical Director of a specialised health service: Lifestyle Metabolic.
Terri-Lynne has more than 25 years of experience in the health profession. She is passionate about metabolic health with a focus on providing a holistic health service that achieves positive outcomes anchored in evidence, innovation, and experience. Terri-Lynne is dedicated to breaking down the stigma, bias and shame associated with the label “obesity” and promoting the science behind the concept of obesity as a chronic medical condition.
She sits on several advisory committees at the state and national level to ultimately help clients with diabetes, metabolic syndrome and other health conditions associated with living in a larger body.
Hear Dr Terri-Lynne South being interviewed on Radio National 'Why experts are calling weight loss drug semaglutide a game-changer'
Registration includes
- Access to a recording of the presentation
- Transcript of the audio
- Presentation notes
- Assessment quiz and certificate
- Suggested further reading
Registration types
- On demand recording: from $24 receive a recording and associated documents
- Subscription: $33 monthly to access all Education in Nutrition recordings
- More information on pricing and packages